← Back to Search

Local Anesthetic

ESP Nerve Block for Renal colic for Kidney Stones

Phase 4

Recruiting

Led By Michael Secko, MD

Research Sponsored by Stony Brook University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 minutes after the esp block

Awards & highlights

Study Summary

This trial found that for people with acute renal colic pain, the erector spinae plane block was more effective than the standard of care.

Who is the study for?

This trial is for adults aged 18 to 65 who are experiencing flank pain due to kidney stones and are in the emergency department. They should be generally healthy without serious heart, lung, liver, or kidney problems. Pregnant women and those with allergies to local anesthetics like Ropivacaine can't join. Also excluded are individuals with a history of spine issues or mental disease exacerbations.Check my eligibility

What is being tested?

The study is examining if injecting Ropivacaine (an anesthetic) near the spine (ESP block) is better at managing acute pain from kidney stones compared to standard medications alone. Participants will either receive this injection along with standard care or just the standard treatment.See study design

What are the potential side effects?

Ropivacaine may cause side effects such as low blood pressure, nausea, vomiting, dizziness, numbness around the injection area, and rarely nerve damage. Standard care medications' side effects vary depending on what's used but often include stomach upset and drowsiness.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 20 minutes after esp block

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~20 minutes after esp block

This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 minutes after esp block for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Baseline Pain before intervention

Pain score at 10 minutes

Pain score at 20 minutes

+2 more

Secondary outcome measures

Need for extra opiates

Trial Design

2Treatment groups

Active Control

Group I: ESP Nerve Block for Renal colicActive Control1 Intervention

On top of receiving standard of care, At T8 nerve level, with ultrasound guidance to bathe the nerve

Group II: Standard of careActive Control1 Intervention

Whatever medications the clinician normally treats renal colic with

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stony Brook UniversityLead Sponsor

216 Previous Clinical Trials

39,947 Total Patients Enrolled

Michael Secko, MDPrincipal InvestigatorStonyBrook University Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How can I become a participant in this clinical experiment?

"To qualify for this medical study, potential enrollees must have renal colic and be between the ages of majority (18) and retirement age (65). In total, 24 individuals are being sought."

Answered by AI

How many individuals are currently participating in this research project?

"Affirmative, the data hosted on clinicaltrials.gov confirms that this research study is actively recruiting participants. The trial was initially posted in April 25th 2022 and has recently been updated by May 31st of 2022. 24 individuals are needed for the experiment to be conducted at a single medical centre."

Answered by AI

Has the FDA sanctioned ESP Nerve Block as a viable treatment for Renal colic?

"After evaluating the clinical trial data, our team at Power rated ESP Nerve Block for Renal colic as a 3 on its safety scale - this treatment is fully approved."

Answered by AI

Is this medical trial still accepting participants?

"Affirmative. The information displayed on clinicaltrials.gov demonstrates that this research endeavour, initially published on April 25th 2022, is actively recruiting participants. 24 individuals must be sourced from one medical centre for the study to move forward."

Answered by AI

Are mature adults included in this medical experiment?

"This clinical trial is reserved for individuals aged 18 to 65. There exist 13 studies specifically geared towards younger participants, while 5 are available for those over the age of 65."

Answered by AI

Recent research and studies

International Journal of Clinical PracticeJournal

Erector Spinae Plane Block Vs Non‐steroidal Anti‐inflammatory Drugs for Severe Renal Colic Pain: A Pilot Clinical Feasibility Study

Aydin, Muhammed Enes, Erdal Tekin, Elif Oral Ahiskalioglu, Irem Ates, Selahattin Karagoz, Omerul Faruk Aydin, Fatih Ozkaya, and Ali Ahiskalioglu. 2020. “Erector Spinae Plane Block Vs Non‐steroidal Anti‐inflammatory Drugs for Severe Renal Colic Pain: A Pilot Clinical Feasibility Study”. International Journal of Clinical Practice. Hindawi Limited. doi:10.1111/ijcp.13789.

clinicaltrials.govStudy

Erector Spinae Plane (ESP) Block for Renal Colic

Michael Secko, MD 2022. "Erector Spinae Plane (ESP) Block for Renal Colic". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05323175.